[96a5a0]: / output / allTrials / identified / NCT05494320_identified.json

Download this file

237 lines (237 with data), 9.1 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
{
"info": {
"nct_id": "NCT05494320",
"official_title": "The Effect of ATP-Binding Cassette C2 (ABCC2) Transporter Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin -Based Chemotherapy",
"inclusion_criteria": "1. gastrointestinal cancer Patients ( ≥ stages II ) who receive Oxaliplatin based chemotherapy ( FOLFOX6 ) for adjuvant and metastatic setting.\n2. Eastern Cooperative Oncology Group ( ECOG ) performance ≤ 2.\n3. Adequate bone marrow functions ,liver functions and renal functions.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "1. Patients who have any clinical neuropathy.\n2. Pateints with Diabetes mellitus.\n3. Serious comorbid systemic disorder incompatible with study.\n4. Pregnancy.\n5. Other primary tumors.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. gastrointestinal cancer Patients ( ≥ stages II ) who receive Oxaliplatin based chemotherapy ( FOLFOX6 ) for adjuvant and metastatic setting.",
"criterions": [
{
"exact_snippets": "gastrointestinal cancer Patients",
"criterion": "gastrointestinal cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "( ≥ stages II )",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": {
"operator": ">=",
"value": 2,
"unit": "N/A"
}
}
]
},
{
"exact_snippets": "receive Oxaliplatin based chemotherapy ( FOLFOX6 )",
"criterion": "chemotherapy regimen",
"requirements": [
{
"requirement_type": "type",
"expected_value": "Oxaliplatin based chemotherapy ( FOLFOX6 )"
}
]
},
{
"exact_snippets": "adjuvant and metastatic setting",
"criterion": "treatment setting",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"adjuvant",
"metastatic"
]
}
]
}
]
},
{
"line": "2. Eastern Cooperative Oncology Group ( ECOG ) performance ≤ 2.",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group ( ECOG ) performance ≤ 2",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "performance status",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Patients who have any clinical neuropathy.",
"criterions": [
{
"exact_snippets": "Patients who have any clinical neuropathy",
"criterion": "clinical neuropathy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "2. Pateints with Diabetes mellitus.",
"criterions": [
{
"exact_snippets": "Diabetes mellitus",
"criterion": "Diabetes mellitus",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "3. Serious comorbid systemic disorder incompatible with study.",
"criterions": [
{
"exact_snippets": "Serious comorbid systemic disorder incompatible with study.",
"criterion": "comorbid systemic disorder",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "serious"
},
{
"requirement_type": "compatibility with study",
"expected_value": false
}
]
}
]
},
{
"line": "4. Pregnancy.",
"criterions": [
{
"exact_snippets": "Pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "5. Other primary tumors.",
"criterions": [
{
"exact_snippets": "Other primary tumors.",
"criterion": "primary tumors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "3. Adequate bone marrow functions ,liver functions and renal functions.",
"criterions": [
{
"exact_snippets": "Adequate bone marrow functions",
"criterion": "bone marrow functions",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "adequate"
}
]
},
{
"exact_snippets": "adequate ... liver functions",
"criterion": "liver functions",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "adequate"
}
]
},
{
"exact_snippets": "adequate ... renal functions",
"criterion": "renal functions",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": "adequate"
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}